Exhibit 99.1



tenet_logoa03.jpg
 
Tenet Reports Results for the Second Quarter Ended June 30, 2018
Tenet reported net income from continuing operations available to Tenet common shareholders of $24 million or $0.23 per diluted share in the second quarter of 2018 compared to a net loss of $56 million or $0.56 per diluted share in the second quarter of 2017. After adjusting for certain items, which totaled $27 million or $0.26 per share in the second quarter of 2018, Tenet reported Adjusted diluted earnings per share from continuing operations of $0.49 in the second quarter of 2018 compared to an Adjusted diluted loss per share of $0.17 in the second quarter of 2017.
Adjusted EBITDA was $634 million in the second quarter of 2018 compared to $570 million in the second quarter of 2017. Adjusted EBITDA in the second quarter of 2018 consisted of $345 million in the Hospital segment, $198 million in the Ambulatory segment and $91 million in the Conifer segment.
Net cash provided by operating activities was $461 million in the first half of 2018, an increase of $60 million when compared to $401 million in the first half of 2017. Free Cash Flow was $193 million, an increase of $140 million when compared to $53 million in the first half of 2017. Adjusted Free Cash Flow was $259 million, a $142 million increase when compared to $117 million in the first half of 2017.
Hospital segment same-hospital net patient revenue grew 3.2 percent. Admissions decreased 2.3 percent, adjusted admissions decreased 0.2 percent, and revenue per adjusted admission increased 3.5 percent.
Ambulatory Care segment same-facility system-wide revenue grew 6.9 percent, with cases up 4.3 percent and revenue per case up 2.4 percent. Surgical revenue grew 6.6 percent, with cases up 3.4 percent and revenue per surgical case up 3.1 percent.
Conifer segment revenues decreased 3.5 percent primarily due to divestitures by Tenet and other customers.
2018 Outlook includes an increase in net income from continuing operations available to Tenet common shareholders to $115 million to $186 million, Adjusted EBITDA is unchanged at $2.550 billion to $2.650 billion, an increase in diluted earnings per share from continuing operations to $1.11 to $1.79 and an increase in Adjusted diluted earnings per share from continuing operations to $1.54 to $1.88.

DALLAS – August 6, 2018 – Tenet Healthcare Corporation (NYSE: THC) reported net income from continuing operations available to Tenet common shareholders of $24 million in the second




The following information was filed by Tenet Healthcare Corp (THC) on Monday, August 6, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Tenet Healthcare Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Tenet Healthcare Corp.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account